» Articles » PMID: 8006085

Genetic Deficiency in Low Density Lipoprotein Receptor-related Protein Confers Cellular Resistance to Pseudomonas Exotoxin A. Evidence That This Protein is Required for Uptake and Degradation of Multiple Ligands

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 1994 Mar 1
PMID 8006085
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The low density lipoprotein receptor-related protein (LRP) is a large multifunctional receptor implicated in the cellular uptake of functionally diverse ligands. Biochemical evidence suggests that LRP is a clearance receptor for apoE-rich remnant lipoproteins, lipoprotein lipase, alpha 2-macroglobulin/protease complexes, plasminogen activator/inhibitor complexes, the active protease tissue-type plasminogen activator and exotoxin A from Pseudomonas aeruginosa. Mice genetically deficient in LRP die early during gestation, underscoring the essential physiological role of this gene in vivo. To study the effect of LRP deficiency at the cellular level, we have used Pseudomonas exotoxin A (PEA) to select murine embryonic fibroblasts that are genetically deficient in LRP. Our results demonstrate that this single gene defect is sufficient to confer resistance to PEA on cultured cells. In addition, embryonic fibroblasts lacking LRP are unable to bind, internalize and degrade methylamine-activated alpha 2-macroglobulin and complexes of urokinase with plasminogen activator inhibitor-1. Furthermore, cellular uptake and degradation of receptor-associated protein, a 39 kDa accessory protein of LRP, is reduced by 90% in the absence of LRP. These results provide genetic evidence for the multifunctional nature of LRP and its crucial role in protease/inhibitor complex metabolism.

Citing Articles

Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with Wnt pathway dysregulation.

Alhashmi M, Gremida A, Maharana S, Antonaci M, Kerr A, Fu S Bone Res. 2025; 13(1):17.

PMID: 39865089 PMC: 11770177. DOI: 10.1038/s41413-024-00393-x.


Characterization of Stealth Liposome-Based Nanoparticles Encapsulating the ACAT1/SOAT1 Inhibitor F26: Efficacy and Toxicity Studies In Vitro and in Wild-Type Mice.

Lee J, De La Torre A, Rawlinson F, Ness D, Lewis L, Hickey W Int J Mol Sci. 2024; 25(17).

PMID: 39273099 PMC: 11394700. DOI: 10.3390/ijms25179151.


Efficient LRP1-Mediated Uptake and Low Cytotoxicity of Peptide L57 In Vitro Shows Its Promise as CNS Drug Delivery Vector.

Rodrigues J, Prajapati N, DeCoster M, Poh S, Murray T J Pharm Sci. 2020; 110(2):824-832.

PMID: 33065129 PMC: 7855644. DOI: 10.1016/j.xphs.2020.09.019.


Inhibition of sphingolipid synthesis improves outcomes and survival in GARP mutant mice, a model of motor neuron degeneration.

Petit C, Lee J, Boland S, Swarup S, Christiano R, Lai Z Proc Natl Acad Sci U S A. 2020; 117(19):10565-10574.

PMID: 32345721 PMC: 7229683. DOI: 10.1073/pnas.1913956117.


LRP1 is required for novobiocin-mediated fibronectin turnover.

Boel N, Hunter M, Edkins A Sci Rep. 2018; 8(1):11438.

PMID: 30061663 PMC: 6065439. DOI: 10.1038/s41598-018-29531-2.